Press Releases ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
4.86 ^USD	+1.04%		-5.63%	+7.52%

May. 09	Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M	MT
May. 09	Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProPhase Labs : Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test - Form 8-K	May. 09	PU
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.	May. 09	AQ
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9	May. 02	AQ
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024	Apr. 25	AQ
ProPhase Labs Unveils Project ZenQ-AI	Apr. 16	AQ
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024	Apr. 10	AQ
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Apr. 01	AQ
MENADNA and ProPhase Labs' (NASDAQ: PRPH) Wholly-Owned Subsidiary, Nebula Genomics, Announce Strategic Partnership to Enhance Genomic Testing in Jordan, Oman and Iraq	Mar. 18	AQ
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives	Mar. 15	AQ
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024	Mar. 08	AQ
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART	Feb. 20	AQ
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir	Feb. 14	AQ
Sidus Space Appoints Bill White as Chief Financial Officer	Feb. 09	AQ
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics	Jan. 30	AQ
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts	Jan. 23	AQ
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024	Jan. 04	AQ
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023	Nov. 09	AQ
ProPhase Labs : Corporate Presentation	Nov. 06	PU
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time	Nov. 02	AQ
ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.	23-10-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Press Releases

Filters